| Name | Title | Contact Details |
|---|
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.
Sunrise Medical is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
At LivaNova we strive to help where it really counts, where it truly matters the most. Where every single effort, of each one of us, is transformational and expected to leave a lasting mark. That is why at LivaNova we make each innovation count: global, accessible, relevant and breakthrough. Transforming medical innovation into meaningful solutions, into a sustainable healthcare system and ultimately into healthier and – importantly - better lives.
GlucoTec is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.